Ryan Langston
Stock Analyst at TD Cowen
(0.99)
# 3,932
Out of 5,044 analysts
260
Total ratings
46.4%
Success rate
-1.5%
Average return
Main Sectors:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Rated: Hold | $430 → $402 | $379.30 | +5.98% | 19 | Oct 9, 2026 | |
| EHC Encompass Health | Reiterated: Buy | $140 | $123.33 | +13.52% | 4 | Oct 2, 2026 | |
| SGRY Surgery Partners | Rated: Buy | $19 | $13.89 | +36.79% | 13 | Sep 18, 2026 | |
| PIII P3 Health Partners | Reiterated: Hold | $13 | $4.95 | +162.63% | 12 | Aug 26, 2026 | |
| AGL agilon health | Reiterated: Hold | $55 → $95 | $82.39 | +15.31% | 11 | Aug 7, 2026 | |
| DVA DaVita | Upgraded: Buy | $201 → $220 | $179.25 | +22.73% | 12 | Aug 7, 2026 | |
| ADUS Addus HomeCare | Rated: Buy | $131 | $114.33 | +14.58% | 23 | Aug 4, 2026 | |
| ALHC Alignment Healthcare | Rated: Buy | $25 → $21 | $7.55 | +178.33% | 10 | Aug 3, 2026 | |
| HUM Humana | Rated: Hold | $350 → $370 | $431.87 | -14.33% | 16 | Jul 31, 2026 | |
| ACHC Acadia Healthcare Company | Reiterated: Buy | $36 | $29.25 | +23.08% | 16 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $65 | $65.36 | -0.55% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $197 | $177.35 | +11.08% | 17 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $431 | $451.09 | -4.45% | 16 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $230 → $200 | $196.93 | +1.56% | 19 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $233 → $263 | $263.78 | -0.30% | 9 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $465 | $412.70 | +12.67% | 15 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $50 | $37.55 | +33.16% | 13 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $20.85 | +43.88% | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $391 → $333 | $282.43 | +17.91% | 4 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $12.42 | n/a | 1 | Aug 9, 2024 |
UnitedHealth Group
Oct 9, 2026
Rated: Hold
Price Target: $430 → $402
Current: $379.30
Upside: +5.98%
Encompass Health
Oct 2, 2026
Reiterated: Buy
Price Target: $140
Current: $123.33
Upside: +13.52%
Surgery Partners
Sep 18, 2026
Rated: Buy
Price Target: $19
Current: $13.89
Upside: +36.79%
P3 Health Partners
Aug 26, 2026
Reiterated: Hold
Price Target: $13
Current: $4.95
Upside: +162.63%
agilon health
Aug 7, 2026
Reiterated: Hold
Price Target: $55 → $95
Current: $82.39
Upside: +15.31%
DaVita
Aug 7, 2026
Upgraded: Buy
Price Target: $201 → $220
Current: $179.25
Upside: +22.73%
Addus HomeCare
Aug 4, 2026
Rated: Buy
Price Target: $131
Current: $114.33
Upside: +14.58%
Alignment Healthcare
Aug 3, 2026
Rated: Buy
Price Target: $25 → $21
Current: $7.55
Upside: +178.33%
Humana
Jul 31, 2026
Rated: Hold
Price Target: $350 → $370
Current: $431.87
Upside: -14.33%
Acadia Healthcare Company
Jul 30, 2026
Reiterated: Buy
Price Target: $36
Current: $29.25
Upside: +23.08%
Jul 30, 2026
Rated: Hold
Price Target: $65
Current: $65.36
Upside: -0.55%
Jul 29, 2026
Rated: Buy
Price Target: $197
Current: $177.35
Upside: +11.08%
Jul 27, 2026
Rated: Buy
Price Target: $431
Current: $451.09
Upside: -4.45%
Jul 27, 2026
Rated: Hold
Price Target: $230 → $200
Current: $196.93
Upside: +1.56%
Jul 27, 2026
Rated: Buy
Price Target: $233 → $263
Current: $263.78
Upside: -0.30%
Jul 17, 2026
Reiterated: Buy
Price Target: $400 → $465
Current: $412.70
Upside: +12.67%
Jul 14, 2026
Rated: Buy
Price Target: $45 → $50
Current: $37.55
Upside: +33.16%
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $20.85
Upside: +43.88%
Feb 4, 2026
Reiterated: Buy
Price Target: $391 → $333
Current: $282.43
Upside: +17.91%
Aug 9, 2024
Rated: Hold
Price Target: $7
Current: $12.42
Upside: n/a